Zentalis Property Plant And Equipment Net from 2010 to 2024

ZNTL Stock  USD 12.96  0.42  3.35%   
Zentalis PharmaceuticalsL Property Plant And Equipment Net yearly trend continues to be quite stable with very little volatility. The value of Property Plant And Equipment Net is projected to decrease to about 27.8 M. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects Zentalis PharmaceuticalsL's investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2010-12-31
Previous Quarter
41.7 M
Current Value
27.8 M
Quarterly Volatility
20.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zentalis PharmaceuticalsL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zentalis main balance sheet or income statement drivers, such as Net Interest Income of 469.1 K, Interest Income of 469.1 K or Depreciation And Amortization of 1.5 M, as well as many exotic indicators such as Price To Sales Ratio of 23.9 K, Dividend Yield of 0.0 or PTB Ratio of 2.15. Zentalis financial statements analysis is a perfect complement when working with Zentalis PharmaceuticalsL Valuation or Volatility modules.
  
This module can also supplement Zentalis PharmaceuticalsL's financial leverage analysis and stock options assessment as well as various Zentalis PharmaceuticalsL Technical models . Check out the analysis of Zentalis PharmaceuticalsL Correlation against competitors.

Latest Zentalis PharmaceuticalsL's Property Plant And Equipment Net Growth Pattern

Below is the plot of the Property Plant And Equipment Net of Zentalis PharmaceuticalsLlc over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. Zentalis PharmaceuticalsL's Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zentalis PharmaceuticalsL's overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net10 Years Trend
Slightly volatile
   Property Plant And Equipment Net   
       Timeline  

Zentalis Property Plant And Equipment Net Regression Statistics

Arithmetic Mean12,079,841
Geometric Mean1,408,733
Coefficient Of Variation166.22
Mean Deviation16,544,434
Median260,000
Standard Deviation20,079,455
Sample Variance403.2T
Range52.6M
R-Value0.73
Mean Square Error203.7T
R-Squared0.53
Significance0
Slope3,271,140
Total Sum of Squares5644.6T

Zentalis Property Plant And Equipment Net History

202427.8 M
202341.7 M
202250.1 M
202152.8 M
20203.6 M
20192.8 M

About Zentalis PharmaceuticalsL Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Zentalis PharmaceuticalsL income statement, its balance sheet, and the statement of cash flows. Zentalis PharmaceuticalsL investors use historical funamental indicators, such as Zentalis PharmaceuticalsL's Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Although Zentalis PharmaceuticalsL investors may use each financial statement separately, they are all related. The changes in Zentalis PharmaceuticalsL's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zentalis PharmaceuticalsL's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Zentalis PharmaceuticalsL Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Zentalis PharmaceuticalsL. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Net41.7 M27.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:
Check out the analysis of Zentalis PharmaceuticalsL Correlation against competitors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Zentalis Stock analysis

When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.47)
Return On Assets
(0.29)
Return On Equity
(0.67)
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.